Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2019 Financial Results
November 19, 2019 16:15 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies...